We found that a large number of genes showed dynamic differential expression during cancer progression: 31 296 genes for Luminal tumors, 17 827 for HER2‐enriched tumors, and 18 505 genes for Basal‐like tumors (see Data S1). This evidence concerns the gene ERBB2 and cancer.